# ElectroNic Hydroxyurea AdhereNCE: A Strategy to Improve Hydroxyurea Adherence in Patients With Sickle Cell Disease

> **NCT02578017** · NA · COMPLETED · sponsor: **Nationwide Children's Hospital** · enrollment: 71 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **BEHAVIORAL:** Mobile DOT

## Key facts

- **NCT ID:** NCT02578017
- **Lead sponsor:** Nationwide Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2019-06
- **Final completion:** 2019-06
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2019-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02578017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02578017, "ElectroNic Hydroxyurea AdhereNCE: A Strategy to Improve Hydroxyurea Adherence in Patients With Sickle Cell Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02578017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*